Abstract:Introduction.Erectile dysfunction (ED) is a common and hard-to-treat complication of diabetes mellitus (DM). Multiple lines of evidence have shown that poly(ADP-ribose) polymerase (PARP) activation plays an important role in neurovascular dysfunction in diabetes, which is the crucial mechanism for diabetic ED.Aim.To investigate the preventive benefit of a PARP inhibitor in a rat model of ED induced by diabetes.Methods.Established streptozotocin-diabetic male Sprague-Dawley rats were given PJ-34, a selective PARP inhibitor, by oral gavage at a dose of 10 mg/kg twice daily for 8 weeks. Erectile responses under electrical stimulation of the cavernous nerve, PARP activity and reactive oxygen species (ROS) production were measured. Nitric oxide synthase (NOS) isoforms were evaluated by Western blot and real-time quantitative PCR. Nuclear factor-kappa B activition and apoptosis in corpus cavernosa (CC) were also investigated.Main Outcome Measures.The effects of PARP inhibition on the development of diabetic ED were determined.Results.Diabetes markedly attenuated the erectile responses (intracavernosal pressure/mean systemic arterial blood pressure) and these were partially prevented by PJ-34 treatment. Promoted oxidative stress associated PARP activation was found in CC from vehicle-treated diabetic rats. PJ-34 blocked PARP activity and the diabetes-associated ROS generation. Decreased expression and activity of constitutive NOS (cNOS), including endothelial NOS (eNOS) and neuronal NOS (nNOS), associated with enhanced inducible NOS (iNOS) expression and activity were observed in vehicle-treated diabetic rats. Although PJ-34 had no effect on eNOS expression, it significantly prevented the decrease in nNOS expression and cNOS activity, and inhibited iNOS expression and activity in diabetic rats. PARP blockade by PJ-34 to some extent prevented diabetes-associated apoptosis and NF-kappa B activation.Conclusions.Our results indicate that PARP activation plays an important role in the pathogenesis of diabetic ED and PARP inhibition may be a promising strategy to prevent development of diabetic ED. Wan ZH, Li WZ, Li YZ, Chen L, Li GH, Hu WF, Peng S, Yu JJ, and Guo F. Poly(ADP-Ribose) polymerase inhibition improves erectile function in diabetic rats. J Sex Med 2011;8:1002-1014.

Poly (Adp-Ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hyperhomocysteinemia in Rats

Poly (Adp-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in Apoe-/- Mice with Hyperhomocysteinemia

PKC/NADPH Oxidase Are Involved in the Protective Effect of Pioglitazone in High Homocysteine-Induced Paracrine Dyfunction in Endothelial Progenitor Cells.

Current progress on the mechanisms of hyperhomocysteinemia-induced vascular injury and use of natural polyphenol compounds

Poly(ADP‐ribose)polymerase 1 Inhibition Protects Against Age‐dependent Endothelial Dysfunction

Polydatin improves vascular endothelial function by maintaining mitochondrial homeostasis under high glucose conditions

Protection of Endothelial Cells Against Ang II-induced Impairment: Involvement of Both PPARα and PPARγ Via PI3K/Akt Pathway

Poly(ADP-ribose) Polymerase 1 Inhibition Protects Cardiomyocytes from Inflammation and Apoptosis in Diabetic Cardiomyopathy.

Inhibition of Inflammatory Factors by Parthenolide in Human Renal Mesangial Cells under Hyperglycemic Condition

Effect of hyperhomocysteinemia on ischemic disease in rats

Poly(ADP-ribose) Polymerase Inhibition Prevents Reactive Oxygen Species Induced Inhibition of Aldehyde Dehydrogenase2 Activity

INHIBITION OF THE ACTIVITY OF POLY (ADP-RIBOSE) POLYMERASE REDUCES HEART ISCHAEMIA/REPERFUSION INJURY VIA SUPPRESSING JNK MEDIATED AIF TRANSLOCATION

Poly (adp‐ribose) Polymerase Inhibition Protects Against Myocardial Ischaemia/reperfusion Injury Via Suppressing Mitophagy

Poly(ADP‐ribose) Polymerase 1 Deficiency Increases Nitric Oxide Production and Attenuates Aortic Atherogenesis Through Downregulation of Arginase II

Poly(ADP-ribose) Polymerase 1 Inhibition Protects Against Low Shear Stress Induced Inflammation.

Poly(Adp-Ribose) Polymerase Inhibition Improves Erectile Function In Diabetic Rats

PJ34, a PARP1 inhibitor, promotes endothelial repair in a rabbit model of high fat diet-induced atherosclerosis.

PARP1 Inhibitor (PJ34) Improves the Function of Aging-Induced Endothelial Progenitor Cells by Preserving Intracellular NAD+ Levels and Increasing SIRT1 Activity

FBXW7 alleviates hyperglycemia-induced endothelial oxidative stress injury via ROS and PARP inhibition

[Poly (Adp-Ribose) Polymerase Inhibition Attenuates Ischemia/reperfusion Induced Myocardial Injury in Rat Via Reducing Myocardial Nuclear Factor Κb Activity].

Vascular Remodeling, Oxidative Stress, and Disrupted PPARγ Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance